Trial Details
RECRUITINGBasic Information
| Clinical ID | c212 |
|---|---|
| Identifier | NCT06958536 |
| Trial Title | A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: SAR442970|DRUG: Placebo |
Participant Information
| Sponsor | Sanofi |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-06-03 |
|---|---|
| Primary Completion Date | 2026-12-17 |
| Completion Date | 2029-10-17 |